5 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the five best low price pharma stocks to invest in.
Teva Pharmaceutical Industries Ltd (TEVA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 665,092 | $9,384,449 | +1% | 1.83% |
| 2. | ARK Investment Management Catherine D. Wood | 192,136 | $2,711,039 | -14% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.60 | 104,500 | Director | 220,442 | 2019-06-04 | Filing | |
| $8.98 | 111,000 | Director | 115,942 | 2019-06-03 | Filing | |
| $21.92 | 2,000 | Officer | 6,445 | 2018-08-03 | Filing | |
| $19.32 | 250,000 | Director | 1,500,000 | 2018-05-10 | Filing | |
| $19.21 | 500,000 | Director | 1,250,000 | 2018-05-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.52 | 77,550 | 203,691 | 2024-03-06 | Filing | ||
| $13.52 | 26,053 | 98,943 | 2024-03-05 | Filing | ||
| $13.52 | 22,576 | 69,770 | 2024-03-05 | Filing | ||
| $13.52 | 1,427 | 15,219 | 2024-03-05 | Filing | ||
| $13.52 | 100,000 | 382,590 | 2024-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 41,664,861 | $434,981,150 | 0.01% | |
| 2. | 40,327,407 | $421,018,130 | 27.96% | |
| 3. | 34,383,192 | $404,315,484 | 6.68% | |
| 4. | 34,457,656 | $359,737,929 | 17.31% | |
| 5. | 28,128,744 | $293,664,087 | 2.47% |
News See All
5 Best Healthcare Stocks to Buy Under $20
In this article, we will be taking a look at the 5 best healthcare stocks to buy under $20.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2023 Earnings Call Transcript
Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $1, expectations were $0.75.
Here’s Why Teva Pharmaceutical Industries Limited (TEVA) Rose in Q3
Sound Shore Management, an investment management firm, has released its investor letter for the third quarter of 2023. A copy of the same can be downloaded here.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Q3 2023 Teva Pharmaceutical Industries Limited Earnings Conference Call. My name is Alex. I'll be coordinating the call today.
13 Most Undervalued Pharma Stocks To Buy According To Analysts
In this piece, we will take a look at the 13 most undervalued pharmaceutical stocks to buy according to analysts.
Top 30 Oncology Companies in the World
In this article, we shall cover the top 30 oncology companies in the world.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Q2 2023 Teva Pharmaceutical Industries Limited earnings conference call. My name is Alex. I'll be coordinating the call today. [Operator instructions].
5 Best Medical Stocks Under $10
In this piece, we will take a look at the five best medical stocks under $10.
Analysts are Upgrading These 10 Stocks
US stock markets are wavering as politicians continue their talks about the debt ceiling problem.
Billionaire Hedge Funds
